Small-molecule activator of UNC-51-like kinase 1 (ULK1) that induces cytoprotective autophagy for Parkinson's disease treatment

L Ouyang, L Zhang, S Zhang, D Yao… - Journal of medicinal …, 2018 - ACS Publications
UNC-51-like kinase 1 (ULK1), the yeast Atg1 ortholog, is the sole serine-threonine kinase
and initiating enzyme in autophagy, which may be regarded as a target in Parkinson's …

Pharmacological intervention to restore connectivity deficits of neuronal networks derived from ASD patient iPSC with a TSC2 mutation

M Alsaqati, VM Heine, AJ Harwood - Molecular autism, 2020 - Springer
Background Tuberous sclerosis complex (TSC) is a rare genetic multisystemic disorder
resulting from autosomal dominant mutations in the TSC1 or TSC2 genes. It is characterised …

The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target

ST Xue, K Li, Y Gao, LY Zhao, Y Gao, H Yi, JD Jiang… - Autophagy, 2020 - Taylor & Francis
Although macroautophagy/autophagy is involved in hepatocellular carcinoma (HCC)
initiation and development and has been identified as a mechanism of HCC therapy …

Mechanisms of autophagy and relevant small-molecule compounds for targeted cancer therapy

J Zhang, G Wang, Y Zhou, Y Chen, L Ouyang… - Cellular and Molecular …, 2018 - Springer
Autophagy is an evolutionarily conserved, multi-step lysosomal degradation process for the
clearance of damaged or superfluous proteins and organelles. Accumulating studies have …

Autophagy modulation in cancer therapy: Challenges coexist with opportunities

Y Wu, A Wang, G Feng, X Pan, W Shuai, P Yang… - European Journal of …, 2024 - Elsevier
Autophagy, a crucial intracellular degradation process facilitated by lysosomes, plays a
pivotal role in maintaining cellular homeostasis. The elucidation of autophagy key genes …

Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy

R Zhao, J Fu, L Zhu, Y Chen, B Liu - Journal of hematology & oncology, 2022 - Springer
Non-coding RNAs (ncRNAs) have been defined as a class of RNA molecules transcribed
from the genome but not encoding proteins, such as microRNAs, long non-coding RNAs …

[HTML][HTML] Small molecules targeting programmed cell death in breast cancer cells

S Maniam, S Maniam - International journal of molecular sciences, 2021 - mdpi.com
Targeted chemotherapy has become the forefront for cancer treatment in recent years. The
selective and specific features allow more effective treatment with reduced side effects. Most …

Enhanced VEGF secretion and blood–brain barrier disruption: Radiation‐mediated inhibition of astrocyte autophagy via PI3K‐AKT pathway activation

S Zhang, M Li, Y Qiu, J Wu, X Xu, Q Ma, Z Zheng, G Lu… - Glia, 2024 - Wiley Online Library
Radiation‐induced damage to the blood–brain barrier (BBB) is the recognized pathological
basis of radiation‐induced brain injury (RBI), a side effect of head and neck cancer …

Discovery of a novel dual-target inhibitor of ERK1 and ERK5 that induces regulated cell death to overcome compensatory mechanism in specific tumor types

G Wang, Y Zhao, Y Liu, D Sun, Y Zhen… - Journal of Medicinal …, 2020 - ACS Publications
ERK1 and ERK5 are proposed to have pivotal roles in several types of cancer. Under some
circumstance, ERK5 may provide a common bypass route, which rescues proliferation upon …

Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting DDX3

R Fu, P Yang, Z Li, W Liu, S Amin, Z Li - Cell death & disease, 2019 - nature.com
Colorectal cancer (CRC) is a common malignant gastrointestinal tumor with high mortality
worldwide. Drug resistance and cytotoxicity to normal cells are the main causes of …